494 related articles for article (PubMed ID: 36695415)
1. Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
[TBL] [Abstract][Full Text] [Related]
2. TNF-α blockers for the treatment of Kawasaki disease in children.
Yamaji N; da Silva Lopes K; Shoda T; Ishitsuka K; Kobayashi T; Ota E; Mori R
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012448. PubMed ID: 31425625
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for the treatment of Kawasaki disease in children.
Green J; Wardle AJ; Tulloh RM
Cochrane Database Syst Rev; 2022 May; 5(5):CD011188. PubMed ID: 35622534
[TBL] [Abstract][Full Text] [Related]
5. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids for the treatment of Kawasaki disease in children.
Wardle AJ; Connolly GM; Seager MJ; Tulloh RM
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011188. PubMed ID: 28129459
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Bus SR; de Haan RJ; Vermeulen M; van Schaik IN; Eftimov F
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD001797. PubMed ID: 38353301
[TBL] [Abstract][Full Text] [Related]
8. Clinically-indicated replacement versus routine replacement of peripheral venous catheters.
Webster J; Osborne S; Rickard CM; Marsh N
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007798. PubMed ID: 30671926
[TBL] [Abstract][Full Text] [Related]
9. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
Ni H; Aye SZ; Naing C
Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
[TBL] [Abstract][Full Text] [Related]
10. Interventions for reducing inflammation in familial Mediterranean fever.
Yin X; Tian F; Wu B; Xu T
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
[TBL] [Abstract][Full Text] [Related]
11. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
[TBL] [Abstract][Full Text] [Related]
12. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
13. Interventions for necrotizing soft tissue infections in adults.
Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
[TBL] [Abstract][Full Text] [Related]
14. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
[TBL] [Abstract][Full Text] [Related]
16. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
[TBL] [Abstract][Full Text] [Related]
17. Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
Burton JK; Craig L; Yong SQ; Siddiqi N; Teale EA; Woodhouse R; Barugh AJ; Shepherd AM; Brunton A; Freeman SC; Sutton AJ; Quinn TJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013307. PubMed ID: 34826144
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
19. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin for the treatment of childhood encephalitis.
Iro MA; Martin NG; Absoud M; Pollard AJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
